Part of the blame for limited testing availability for the coronavirus pandemic could fall squarely on the Centers for Disease Control (CDC), which used highly restrictive language in the health protection agency’s emergency use authorization for COVID-19 testing.

For the first time in nearly 50 years, the U.S. Food and Drug Administration will examine asbestos testing for talc powders and cosmetics at a hearing.

South San Francisco-based Veracyte entered a multi-year partnership with AstraZeneca’s hematology research and development unit, Acerta Pharma.

In this webinar, Dr. Benjamin Darbro and Alyssa Hahn will discuss how their organization is using Natural Language Processing to transform unstructured source data into clinical and research decision support insights.